Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
Transplantation ; 71(11): 1512-4, 2001 Jun 15.
Article in English | MEDLINE | ID: mdl-11435957

ABSTRACT

BACKGROUND: After xenograft reperfusion, complement activation may lead to generation of anaphylatoxins and cardiocirculatory instability of the recipient. METHODS: In 13 cynomolgus recipients of either unmodified or human decay accelerating factor transgenic porcine kidneys cardiocirculatory parameters were measured by single indicator transpulmonary thermodilution. RESULTS: After graft reperfusion, recipient cardiac output decreased by 25.4% (P<0.05), intrathoracic blood volume by 22.8% (P<0.05), extravascular lung water increased slightly (P=n.s.). The impairment in cardiac output was neither influenced by the graft's weight or human decay accelerating factor transgenicity. sC3a and sC5b-9 complement levels in the recipient monkeys showed a sharp peak upon reperfusion. CONCLUSIONS: After reperfusion a marked and significant cardiodepression accompanied by relative volume depletion were observed. Analysis of volume status ruled out a mere volume shift as the underlying reason for the observed drop in cardiac output. These data may be relevant for the perioperative management of human recipients of discordant xenografts in the future.


Subject(s)
Kidney Transplantation , Renal Circulation , Reperfusion Injury/physiopathology , Transplantation, Heterologous , Animals , Animals, Genetically Modified , Blood Volume , Body Water/metabolism , CD55 Antigens/genetics , Cardiac Output , Complement C3a/analysis , Complement Membrane Attack Complex/analysis , Hemodynamics , Humans , Lung/metabolism , Macaca fascicularis , Swine , Thermodilution
2.
Intensive Care Med ; 24(11): 1157-62, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9876978

ABSTRACT

OBJECTIVES: Critically ill patients are often transferred due to the growing number of diagnostic procedures required to be performed outside the intensive care unit. These transfers have proved to be very critical. The aim of this study was to evaluate predictors for the deterioration of respiratory function in critically ill patients after transfer. DESIGN: Prospective, clinical, observational study. SETTING: 1800-bed university teaching hospital. SUBJECTS: 98 mechanically ventilated patients were investigated during transfer. MEASUREMENT AND MAIN RESULTS: Before transfer, all patients were classified according to the Acute Physiology and Chronic Health Evaluation (APACHE) II score and the Therapeutic Intervention Scoring System (TISS). Haemodynamics and arterial blood gases were measured at 11 different times. Arterial oxygen tension (PaO2), fractional inspired oxygen (FIO2), PaO2/FIO2 ratio, lowest PaO2/FIO2 ratio, minimal PaO2 and maximal FIO2, APACHE II score, TISS before transfer, age and duration of transfer were analysed as potential predictors for deterioration of respiratory function after transfer. Variables were analysed using Classification and Regression Trees and Clustering by Response. In 54 transports (55%) there was a decrease in the PaO2/FIO2 ratio, and a decrease of more than 20% from baseline was noted in 23 of the transferred patients (24%). Age > 43 years and FIO2 > 0.5 were identified as predictors for respiratory deterioration. CONCLUSIONS: Our predictors were able to indicate deterioration after transfer correctly in 20 of 22 patients (91%), combined with a false-positive rate in 17 of 49 (35%).


Subject(s)
APACHE , Critical Illness , Patient Transfer , Respiratory Insufficiency/etiology , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Blood Gas Analysis , Cluster Analysis , Disease Progression , Female , Hemodynamics , Humans , Male , Middle Aged , Monitoring, Physiologic , Predictive Value of Tests , Prospective Studies , Regression Analysis , Reproducibility of Results , Respiration, Artificial , Respiratory Insufficiency/metabolism , Respiratory Insufficiency/physiopathology , Respiratory Insufficiency/therapy , Risk Factors
3.
Intensive Care Med ; 26(9): 1252-8, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11089750

ABSTRACT

OBJECTIVE: Capillary leakage syndrome (CLS) is a frequent complication in sepsis, characterized by loss of intravasal fluids leading to generalized edema and hemodynamic instability despite massive fluid therapy. In spite of its importance no standardized diagnostic criteria are available for CLS. DESIGN: Prospective clinical study. SETTING: 1,800-bed university hospital PATIENTS: Six septic shock patients with CLS were compared to six control patients. MEASUREMENTS AND RESULTS: CLS was clinically determined by generalized edema, positive fluid balance, and weight gain. Plasma volume was measured by indocyanine green, red blood cell volume by chromium-51 labeled erythrocytes, and colloid osmotic pressure before and 90 min after the administration of 300 ml 20% albumin. Extracellular water (ECW) was measured using the inulin distribution volume and bioelectrical impedance analysis. Red blood cells averaged 20.2 +/- 1.0 ml/ kg body weight in CLS patients and 23.3 +/- 4.1 in controls. ECW was higher in CLS patients than in controls (40.0 +/- 6.9 vs. 21.7 +/- 3.71; p< 0.05). ECW of inulin was correlated with that measured by bioelectrical impedance analysis (r = 0.74, p< 0.01). The increase in colloid osmotic pressure over the 90 min was less in CLS patients than in controls (1.1 +/- 0.3 vs. 2.8 +/- 1.3 mmHg;p< 0.05). CONCLUSION: These results suggest that measurements of an increased ECW using bioelectrical impedance analysis combined with a different response of colloid osmotic pressure to administration of albumin can discriminate noninvasively between patients with and those without CLS.


Subject(s)
Capillary Leak Syndrome/diagnosis , Shock, Septic/complications , Adult , Aged , Albumins/administration & dosage , Capillary Leak Syndrome/etiology , Case-Control Studies , Electric Impedance , Female , Humans , Linear Models , Male , Middle Aged , Osmotic Pressure , Prospective Studies , Statistics, Nonparametric
4.
Intensive Care Med ; 27(9): 1526-31, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11685347

ABSTRACT

OBJECTIVE: To assess the effects of C1 inhibitor (INH) administration and r-SP-C surfactant application on oxygenation and lung histology in an acute respiratory distress syndrome model. DESIGN AND SETTING: Randomized, controlled experimental study in an animal research laboratory. MATERIAL: 36 adult male Sprague-Dawley rats. INTERVENTIONS: Animals were subjected to repetitive lung lavage. Four experimental groups and two control groups were studied: groups 1 and 2 served as controls. Animals of groups 3-6 received 200 U/kg body weight C1-INH (group 3), 25 mg/kg r-SP-C surfactant (group 4) or both (group 5) at 60 min postlavage (pl). Animals of group 6 were treated with 200 U/kg C1-INH1 at 10 min pl. Animals of group 1 were killed 60 min (min) pl, animals of groups 2-6 were killed at 210 min pl. Thereafter the lungs were excised for histological examination. MEASUREMENTS AND RESULTS: Hyaline membrane formation, intra-alveolar neutrophil (PMN) accumulation and intra-alveolar/perivascular haemorrhage were graded semiquantitatively (0-4). Blood gases were determined 120, 150, 180 and 210 min pl. At 210 min pl pO(2) in group 4 (456+/-74 mmHg) and group 5 (387+/-155 mmHg) was significantly higher than in controls (72+/-29 mmHg) or after C1-INH monotherapy (group 3: 120+/-103, group 6: 63+/-12 mmHg). PMN infiltration after C1-INH monotherapy was significantly less severe than in controls. The combination of r-SP-C surfactant and C1-INH led to significantly lower PMN infiltration than surfactant monotherapy. CONCLUSION: In this lavage-induced acute respiratory distress syndrome model the administration of C1-INH might be followed by a higher clinical efficacy of exogenously supplied recombinant SP-C surfactant.


Subject(s)
Complement C1 Inactivator Proteins/therapeutic use , Disease Models, Animal , Oxygen Consumption/drug effects , Proteolipids/therapeutic use , Pulmonary Surfactants/therapeutic use , Recombinant Proteins/therapeutic use , Respiratory Distress Syndrome/drug therapy , Respiratory Distress Syndrome/metabolism , Animals , Biopsy , Blood Gas Analysis , Complement C1 Inactivator Proteins/pharmacology , Drug Evaluation, Preclinical , Drug Therapy, Combination , Male , Neutrophils , Proteolipids/pharmacology , Pulmonary Surfactants/pharmacology , Random Allocation , Rats , Rats, Sprague-Dawley , Recombinant Proteins/pharmacology , Respiratory Distress Syndrome/etiology , Respiratory Distress Syndrome/pathology , Severity of Illness Index , Time Factors
5.
Intensive Care Med ; 28(5): 629-35, 2002 May.
Article in English | MEDLINE | ID: mdl-12029413

ABSTRACT

OBJECTIVE: To compare the effects of different volume replacement therapies on maintenance of plasma volume in septic shock and capillary leakage syndrome. DESIGN AND SETTING: Prospective randomized, controlled animal laboratory study in a university animal laboratory. MEASUREMENTS AND RESULTS: Twenty-five fasted, anaesthetized, mechanically ventilated and multi-catheterized pigs (20.8+/-1.8 kg) received 1 g/kg body weight faeces into abdominal cavity to induce sepsis and were observed over 8 h. Five animals each received volume replacement therapy with modified fluid gelatin 4% or 8% (MFG4%, MFG8%), 6% HES 200/0.5, or Ringer's solution and were compared to controls receiving 6% HES 200/0.5. Infusion rate was titrated to maintain a central venous pressure of 12 mmHg. Plasma volume was determined using (51)Cr-labelled erythrocytes and standard formulae. Albumin escape rate was calculated using technetium (99m)Tc-labelled albumin. Colloid osmotic pressure, systemic haemodynamics and oxygenation were obtained before and 4 and 8 h after induction of sepsis. Plasma volume was reduced in the Ringer's solution group (-46%) but was maintained in HES (+/-0%), MFG4% (+4%), MFG8% (+23%) groups. Albumin escape rate increased in HES (+52%), MFG4% (+47%), MFG8% (+54%) and the Ringer's solution group (+41%) compared to controls. CONCLUSION: In this porcine septic shock model with concomitant capillary leakage syndrome, confirmed by an increased albumin escape rate, the artificial colloids HES, MFG4%, and MFG8% maintained plasma volume and colloid osmotic pressure. These results suggest the intravascular persistency of artificial colloids in the presence of albumin leakage. An editorial regarding this article can be found in the same issue (http://dx.doi.org/10.1007/s00134-002-1283-9)


Subject(s)
Capillary Leak Syndrome/complications , Gelatin/administration & dosage , Hydroxyethyl Starch Derivatives/administration & dosage , Plasma Substitutes/administration & dosage , Plasma Volume/drug effects , Shock, Septic/complications , Albumins/metabolism , Analysis of Variance , Animals , Colloids/administration & dosage , Disease Models, Animal , Fluid Therapy/methods , Hemodynamics/drug effects , Osmotic Pressure , Prospective Studies , Swine
6.
Intensive Care Med ; 25(9): 1017-20, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10501763

ABSTRACT

The extent of complement and contact activation is related to outcome in sepsis. A low functional index of their main blocker C1-esterase inhibitor (C1-INH) is considered as a relative deficiency of C1-INH and might contribute to the development of fatal complications in the intensive care unit. The first results of therapeutic intervention with C1-INH concentrate in septic shock are promising. We report on our experience of C1-INH concentrate administration in a young woman with Caroli's disease as ultimate rescue therapy for septic shock with capillary leakage syndrome after combined liver and kidney transplantation. No focus of infection was detectable and thus surgical intervention was not indicated. Antibiotic therapy at that time included vancomycin, tobramycin, meropenem and fluconazol. Hemodynamic stabilization occurred within hours after administration of C1-INH concentrate. Simultaneously a reduction in vasopressor medication was possible and negative fluid balance was achieved.


Subject(s)
Caroli Disease/complications , Complement C1 Inactivator Proteins/administration & dosage , Enterococcus faecium , Escherichia coli Infections/drug therapy , Gram-Positive Bacterial Infections/drug therapy , Liver Transplantation , Postoperative Complications/drug therapy , Shock, Septic/drug therapy , Adult , Caroli Disease/surgery , Escherichia coli Infections/physiopathology , Female , Gram-Positive Bacterial Infections/physiopathology , Humans , Kidney Transplantation , Postoperative Complications/physiopathology , Salvage Therapy/methods , Shock, Septic/physiopathology
10.
Eur J Anaesthesiol ; 22(7): 541-7, 2005 Jul.
Article in English | MEDLINE | ID: mdl-16045145

ABSTRACT

BACKGROUND AND OBJECTIVE: The aim of this study was to evaluate the value of terminal complement complex (C5b-9) plasma levels as a marker for complement activation in septic shock with concomitant capillary leak syndrome. METHODS: In a prospective animal study 10 fasted, anaesthetized, mechanically ventilated and multi-catheterized pigs (20.6 +/- 1.3 kg) were investigated over a period of 8 h. Sepsis was induced by faecal peritonitis (1 g kg(-1) body weight faeces, n = 5) and compared to controls (n = 5). The animals received 6% hydroxyethyl starch 200/0.5 to maintain a central venous pressure of 12 mmHg. To quantify capillary leak syndrome, albumin escape rate was measured using 99mTc-labelled human serum albumin. Plasma levels of terminal complement complex were measured in a double antibody immunoassay (neoepitope-specific MoAb aE 11 as catching antibody). Immunohistological studies of renal specimens were performed to detect terminal complement complex deposition. RESULTS: Albumen escape rate increased in septic animals (+ 52%) compared to controls (+ 3%, P < 0.05). Plasma levels of terminal complement complex decreased during the study period in both groups. In septic animals this finding was accompanied by a significant deposition of terminal complement complex in renal specimens (P < 0.05). CONCLUSION: We found an activation of the complement system proven by marked deposition of terminal complement complex in renal specimen, while its plasma levels decreased during the study period in septic and control animals. These results suggest that in septic shock with capillary leak syndrome plasma level of terminal complement complex may not be a reliable marker of complement activation.


Subject(s)
Capillary Leak Syndrome/physiopathology , Complement Activation/physiology , Complement C5/metabolism , Complement Membrane Attack Complex/metabolism , Shock, Septic/metabolism , Animals , Biomarkers , Blood Proteins/metabolism , Erythrocyte Volume/physiology , Female , Hematocrit , Hemodynamics , Immunohistochemistry , Kidney/pathology , Laparotomy , Male , Oxygen/blood , Plasma Volume/physiology , Shock, Septic/pathology , Swine
11.
Article in German | MEDLINE | ID: mdl-12469294

ABSTRACT

Central venous catheters are exchanged in cases of malfunction, suspected infections, or when another catheter type is required. It can be replaced by new venipuncture or using a guide wire. The guide wire technique should be used with a defective catheter or when the catheter type is to be changed. It is contraindicated at exit site infections or proven or suspected catheter infections. Due to possible cross contamination of new by old catheter material meticulous aseptic technique is required. A detailed description of the process of catheter exchange using a guide wire with special regard to the aseptic technique is given.


Subject(s)
Catheterization, Central Venous/methods , Bacterial Infections/prevention & control , Catheterization, Central Venous/adverse effects , Contraindications , Disinfectants , Electrocardiography , Humans
12.
Acta Anaesthesiol Scand ; 43(10): 1060-4, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10593472

ABSTRACT

BACKGROUND: The inert gas xenon, known as an anaesthetic for nearly 50 years, is also used as a contrast agent during computerised tomography (CT)-scanning. As xenon has a higher density and viscosity than air, xenon inhalation may increase airway resistance. METHODS: In a retrospective study we investigated the effects of 33% xenon/67% oxygen on airway pressure and cardio-respiratory parameters in 37 long-term mechanically ventilated patients undergoing cerebral blood flow (rCBF) measurements by means of stable xenon-enhanced CT. RESULTS: Xenon administration caused a significant increase in peak airway pressure from 31.6+/-8.0 cm H2O to 42.7+/-16.9 cm H2O. This effect was reproducible, did not occur after reduction of inspiratory flow rate by 50% from 0.56+/-0.15 L x s(-1) to 0.28+/-0.08 L x s(-1), and vanished immediately after termination of xenon delivery. CONCLUSION: Due to the higher density and viscosity of this gas mixture, ventilation with xenon/oxygen produces a higher Reynolds' number than oxygen/air when given at the same flow rate. This means that during xenon ventilation the zone of transition from turbulent to laminar gas flow may be located more peripherally (in smaller airways) than during oxygen/air ventilation with a subsequent increase in airway resistance. Our results indicate that xenon inhalation may cause a clinically relevant increase of peak airway pressure in mechanically ventilated patients.


Subject(s)
Airway Resistance/drug effects , Respiration, Artificial , Xenon/pharmacology , Administration, Inhalation , Adolescent , Adult , Aged , Aged, 80 and over , Blood Pressure/drug effects , Carbon Dioxide/blood , Cerebrovascular Circulation , Female , Heart Rate/drug effects , Humans , Male , Middle Aged , Oxygen/blood , Retrospective Studies , Tomography, X-Ray Computed , Xenon/administration & dosage
13.
Xenotransplantation ; 8(4): 266-72, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11737852

ABSTRACT

At present, the major barrier to successful discordant xenotransplantation of unmodified or complement regulator transgenic porcine xenografts is acute vascular xenograft rejection (AVR). AVR is associated with the intragraft deposition of induced recipient xenoreactive antibodies and subsequent complement activation. In a life-supporting pig to primate kidney xenotransplantation setting using h-DAF transgenic donor organs and postoperative immunosuppression, episodes of AVR were either treated with boluses of cyclophosphamide and steroids or with the same regimen supplemented by a three-day course of C1-Inhibitor, a multifunctional complement regulator. In 8 out of 10 animals stable initial graft function was achieved; in all animals one or more episodes of AVR were observed. When, in 4 animals, C1-Inhibitor was added to the standard anti-rejection treatment regimen, AVR was successfully reversed in 6 out of 7 episodes, while in another group of 4 animals receiving the standard anti-rejection treatment 0 out of 4 episodes of AVR responded to treatment. Response to anti-rejection treatment was associated with a significant increase in recipient survival time. We conclude that AVR of h-DAF transgenic porcine kidneys can be successfully treated by additional short-term fluid phase complement inhibition.


Subject(s)
Antibodies, Heterophile/immunology , CD55 Antigens/physiology , Graft Rejection/prevention & control , Immunosuppressive Agents/therapeutic use , Kidney Transplantation/immunology , Kidney/blood supply , Serine Proteinase Inhibitors/pharmacology , Transplantation, Heterologous/immunology , Animals , Animals, Genetically Modified , CD55 Antigens/genetics , Complement Activation/drug effects , Cyclophosphamide/therapeutic use , Cyclosporine/therapeutic use , Drug Therapy, Combination , Humans , Immunosuppressive Agents/administration & dosage , Kidney Function Tests , Macaca fascicularis , Methylprednisolone/therapeutic use , Prednisolone/therapeutic use , Recombinant Fusion Proteins/physiology , Swine , Time Factors
14.
Acta Anaesthesiol Scand ; 44(4): 410-6, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10757573

ABSTRACT

BACKGROUND: Hepatic dysfunction is a common problem in patients after hemihepatectomy. Treatment with low-dose dopamine has been shown to be beneficial in hemihepatectomy patients. We hypothesized that dopexamine, a synthetic vasoactive catecholamine, due to its specific pharmocodynamic profile may be more effective in reducing hidden ischaemic episodes in the hepato-splanchnic region during and after temporary total cross-clamping of hepatic inflow in these patients. METHODS: The effects of low-dose dopexamine on hepatic venous haemoglobin oxygen saturation (ShvO2), hepatic venous lactate level, monoethylglycinxylid (MEGX) formation, hepatic synthetic function and indicators for hepatic cell damage were studied during hemihepatectomy and for 16 h postoperatively in hemihepatectomy patients and compared to those of low-dose dopamine. In a prospective, double-blind clinical study 20 patients received randomly either dopexamine (DPX) 0.5 microg kg(-1) min(-1) (n=10) or dopamine (DO) 2.5 microg kg(-1) min(-1) (n= 10). Infusions were started after induction of anaesthesia and continued 16 h postoperatively. Hepatic vein, radial and pulmonary artery were catheterized. Measurements were carried out after induction of anaesthesia, after total cross-clamping of hepatic inflow, and at 2 h and 16 h postoperatively. RESULTS: There were no differences in systemic haemodynamics, oxygenation, ShvO2, serum aminotransferases or MEGX levels between the groups. At 16 h postoperatively prothrombin and antithrombin III levels were significantly lower while hepatic venous lactate was significantly higher in the DPX group compared to the DO group. CONCLUSION: In patients undergoing hemihepatectomy, we could not reveal superior hepatoprotective effects of low-dose dopexamine compared to low-dose dopamine.


Subject(s)
Dopamine Agonists/administration & dosage , Dopamine/analogs & derivatives , Hepatectomy , Liver/metabolism , Reperfusion Injury/prevention & control , Vasodilator Agents/administration & dosage , Adult , Aged , Antithrombin III/analysis , Dopamine/administration & dosage , Double-Blind Method , Female , Hemodynamics/drug effects , Hepatic Veins , Humans , Lactic Acid/blood , Lidocaine/analogs & derivatives , Lidocaine/analysis , Liver Function Tests , Male , Middle Aged , Oxygen/blood , Oxyhemoglobins/analysis , Prospective Studies , Prothrombin/analysis , Reperfusion Injury/physiopathology , Transaminases/blood
15.
Crit Care Med ; 27(1): 82-9, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9934898

ABSTRACT

OBJECTIVES: Sepsis is one of the most important predisposing factors for the development of the acute respiratory distress syndrome (ARDS). Alterations of pulmonary surfactant contribute in the pathogenesis of ARDS. However, little is known about surfactant in patients with less severe grades of lung injury related to sepsis or systemic inflammatory response syndrome (SIRS). Therefore, the purpose of this study was to characterize endogenous surfactant in surgical intensive care patients with sepsis or SIRS. DESIGN: Prospective, observational study. SETTING: University-affiliated, interdisciplinary intensive care unit. PATIENTS: Eleven patients after major surgery with SIRS or sepsis included within 12 hrs of onset and 11 controls without infection or lung disease. INTERVENTIONS: Operating room and standard intensive care unit management. MEASUREMENTS AND MAIN RESULTS: Four serial bronchoalveolar lavage samples (BAL) were recovered over 7 days from the patients and single BAL samples were obtained from controls. BAL cells, total protein, surfactant-associated protein A (SP-A), surfactant alveolar transition forms, and surface activity were analyzed. Two of 11 patients met criteria for acute lung injury and six of the 11 patients met ARDS consensus conference criteria but acute lung injury or ARDS was not persistent. The mean Pao2/F(IO)2 for the patients over 7 days was 253.2+/-15.1 (SEM) and Murray's lung injury score was 1.12+/-0.12, indicating mild-to-moderate lung injury. BAL neutrophil counts were increased (p< .01), and the ratio of poorly functioning light aggregate surfactant to superiorly functioning heavy aggregate surfactant was increased compared with controls (0.32+/-0.06 vs. 0.09+/-0.01, p < .05). SP-A was decreased (1.9+/-0.4 vs. 3.5+/-0.6 microg/mL of BAL, p< .05) and there were increases in the ratios of phospholipid to SP-A (p < .05), protein to SP.A (p < .01), and protein to phospholipid (p < .05). The surface tension-lowering ability of purified heavy aggregate surfactant was significantly impaired (15.6+/-1.6 vs. 2.8+/-0.6 milliNewtons/m, p< .05). CONCLUSIONS: These observations show that surgical patients with SIRS or sepsis who have mild-to-moderate lung injury develop surfactant dysfunction detectable within 7 days of onset. We propose, therefore, that therapeutic strategies to modulate these severe surfactant abnormalities should be considered, as these strategies may have the potential to reduce lung injury, which is associated with a high mortality in sepsis.


Subject(s)
Pulmonary Surfactants/metabolism , Respiratory Distress Syndrome/pathology , Respiratory Distress Syndrome/physiopathology , Systemic Inflammatory Response Syndrome/complications , APACHE , Adult , Bronchoalveolar Lavage Fluid/chemistry , Case-Control Studies , Critical Care/methods , Female , Humans , Male , Middle Aged , Postoperative Period , Prospective Studies , Pulmonary Surfactants/analysis , Respiratory Distress Syndrome/etiology
16.
Xenotransplantation ; 7(3): 186-96, 2000 Aug.
Article in English | MEDLINE | ID: mdl-11021664

ABSTRACT

The introduction of h-DAF transgenic porcine organs into pre-clinical pig-to-primate discordant xenotransplantation has led to complete and reliable abrogation of hyperacute xenograft rejection (HAR). Despite additional heavy immunosuppression however, most xenografts are still lost due to acute vascular rejection (AVR), with current treatment protocols being of only limited value. In a life-supporting model of pig-to-primate kidney transplantation, unmodified (n=8) or h-DAF-transgenic (n=9) porcine kidneys were transplanted into cynomolgus monkeys under cyclophosphamide (CyP), cyclosporine and low-dose steroid immunosuppression. Longest recipient survival was 11 days in the control group and 68 days in the h-DAF transgenic group. Stable initial graft function with recipient survival >4 days was generated in eight animals (two controls and six transgenics). In these animals, plasma complement levels were analyzed during ongoing AVR. Compared with baseline levels, a two-fold increase in C3a levels and a four-fold increase in sC5b-9 levels were measured. In parallel to systemic complement activation, increased deposition of C3 and C5b-9 along with massive staining for recipient IgM immunoglobulins was detected in the xenografts on immunohistochemistry. We conclude that acute vascular xenograft rejection of porcine kidneys in cynomolgus monkeys is associated with classical pathway complement activation following binding of induced recipient anti-porcine antibodies. This complement activation can be observed despite membrane bound expression of human complement regulators in the porcine xenografts. Therefore, additional short-term fluid phase complement inhibition seems necessary for the future development of protocols designed for treatment of AVR in the pig-to-primate combination.


Subject(s)
Complement Activation , Graft Rejection/immunology , Kidney Transplantation/immunology , Acute Disease , Animals , Animals, Genetically Modified , Antibodies, Heterophile/analysis , Complement C3a/metabolism , Complement Membrane Attack Complex/metabolism , Cyclophosphamide/pharmacology , Graft Survival , Humans , Immunoglobulin M/analysis , Immunosuppressive Agents/pharmacology , Kidney Transplantation/pathology , Kidney Transplantation/physiology , Macaca fascicularis , Swine , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL